Literature DB >> 11760776

The basis for drug treatment of the overactive bladder.

K E Andersson1, C Chapple, A Wein.   

Abstract

The normal bladder functions, storage and elimination of urine, are dependent on neural circuits in the brain and spinal cord that coordinate the activity of the detrusor and that of the smooth and striated muscles of the outflow region. Disturbances at different levels may cause the overactive bladder (OAB) syndrome, characterized by urge, frequency and urge incontinence. Knowledge about the mechanisms controlling both normal and abnormal micturition is mandatory for the detection of targets for pharmacological intervention. Such targets may be found in the central nervous system (CNS) or peripherally. Several CNS transmitters can modulate voiding, but few drugs with a defined CNS site of action have been demonstrated to be clinically useful. Traditionally, drugs for treatment o

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11760776     DOI: 10.1007/pl00007101

Source DB:  PubMed          Journal:  World J Urol        ISSN: 0724-4983            Impact factor:   4.226


  13 in total

1.  Economic evaluation of sacral neuromodulation in overactive bladder: A Canadian perspective.

Authors:  Magdy M Hassouna; Hamid Sadri
Journal:  Can Urol Assoc J       Date:  2015 Jul-Aug       Impact factor: 1.862

Review 2.  Distribution and functional significance of phosphodiesterase isoenzymes in the human lower urinary tract.

Authors:  Stefan Uckert; Christian G Stief; Margit Mayer; Udo Jonas; Petter Hedlund
Journal:  World J Urol       Date:  2005-12-06       Impact factor: 4.226

Review 3.  Drug-induced urinary retention: incidence, management and prevention.

Authors:  Katia M C Verhamme; Miriam C J M Sturkenboom; Bruno H Ch Stricker; Ruud Bosch
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

Review 4.  Clinical pharmacokinetics and pharmacodynamics of solifenacin.

Authors:  Oxana Doroshyenko; Uwe Fuhr
Journal:  Clin Pharmacokinet       Date:  2009       Impact factor: 6.447

5.  Spontaneous synaptic drive in detrusor smooth muscle: computational investigation and implications for urinary bladder function.

Authors:  Nilapratim Sengupta; Rohit Manchanda
Journal:  J Comput Neurosci       Date:  2019-11-12       Impact factor: 1.621

6.  Effect of rilmakalim on detrusor contraction in the presence and absence of urothelium.

Authors:  Melinda Wuest; Susann Kaden; Oliver W Hakenberg; Manfred P Wirth; Ursula Ravens
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2005-11-11       Impact factor: 3.000

Review 7.  Perspectives on overactive bladder in the elderly population.

Authors:  Masaki Yoshida
Journal:  World J Urol       Date:  2009-11-11       Impact factor: 4.226

8.  New insights into molecular targets for urinary incontinence.

Authors:  Manoj K Poonia; Ginpreet Kaur; Meena Chintamaneni; Ilesh Changela
Journal:  Indian J Pharmacol       Date:  2010-10       Impact factor: 1.200

Review 9.  The role of phosphodiesterases in bladder pathophysiology.

Authors:  Mohammad S Rahnama'i; Stefan Ückert; Ramona Hohnen; Gommert A van Koeveringe
Journal:  Nat Rev Urol       Date:  2013-05-14       Impact factor: 14.432

10.  Bladder dysfunction in mice with experimental autoimmune encephalomyelitis.

Authors:  Cengiz Z Altuntas; Firouz Daneshgari; Guiming Liu; Adebola Fabiyi; Michael Kavran; Justin M Johnson; M Fatih Gulen; Ritika Jaini; Xiaoxia Li; Tara L Frenkl; Vincent K Tuohy
Journal:  J Neuroimmunol       Date:  2008-10-15       Impact factor: 3.478

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.